Tnf Pharmaceuticals, Stock Market Value
| TNFA Stock | 1.29 0.07 5.15% |
| Symbol | TNF |
TNF Pharmaceuticals, Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TNF Pharmaceuticals,. If investors know TNF will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TNF Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.48) | Return On Assets (0.32) | Return On Equity (2.98) |
The market value of TNF Pharmaceuticals, is measured differently than its book value, which is the value of TNF that is recorded on the company's balance sheet. Investors also form their own opinion of TNF Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is TNF Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TNF Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect TNF Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TNF Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if TNF Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TNF Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
TNF Pharmaceuticals, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to TNF Pharmaceuticals,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of TNF Pharmaceuticals,.
| 11/23/2024 |
| 12/23/2024 |
If you would invest 0.00 in TNF Pharmaceuticals, on November 23, 2024 and sell it all today you would earn a total of 0.00 from holding TNF Pharmaceuticals, or generate 0.0% return on investment in TNF Pharmaceuticals, over 30 days. TNF Pharmaceuticals, is related to or competes with Oric Pharmaceuticals, Lyra Therapeutics, Inhibrx, ESSA Pharma, Sensei Biotherapeutics, NextCure, and Nuvation Bio. TNF Pharmaceuticals, is entity of United States More
TNF Pharmaceuticals, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure TNF Pharmaceuticals,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess TNF Pharmaceuticals, upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.41 | |||
| Information Ratio | 0.0483 | |||
| Maximum Drawdown | 41.7 | |||
| Value At Risk | (13.07) | |||
| Potential Upside | 13.71 |
TNF Pharmaceuticals, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for TNF Pharmaceuticals,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as TNF Pharmaceuticals,'s standard deviation. In reality, there are many statistical measures that can use TNF Pharmaceuticals, historical prices to predict the future TNF Pharmaceuticals,'s volatility.| Risk Adjusted Performance | 0.0505 | |||
| Jensen Alpha | 0.4105 | |||
| Total Risk Alpha | 0.1831 | |||
| Sortino Ratio | 0.0517 | |||
| Treynor Ratio | (1.71) |
TNF Pharmaceuticals, Backtested Returns
TNF Pharmaceuticals, appears to be abnormally volatile, given 3 months investment horizon. TNF Pharmaceuticals, owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0322, which indicates the firm had a 0.0322% return per unit of volatility over the last 3 months. We have found twenty-nine technical indicators for TNF Pharmaceuticals,, which you can use to evaluate the volatility of the company. Please review TNF Pharmaceuticals,'s risk adjusted performance of 0.0505, and Coefficient Of Variation of 1910.81 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, TNF Pharmaceuticals, holds a performance score of 2. The entity has a beta of -0.24, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning TNF Pharmaceuticals, are expected to decrease at a much lower rate. During the bear market, TNF Pharmaceuticals, is likely to outperform the market. Please check TNF Pharmaceuticals,'s jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to make a quick decision on whether TNF Pharmaceuticals,'s existing price patterns will revert.
Auto-correlation | 0.73 |
Good predictability
TNF Pharmaceuticals, has good predictability. Overlapping area represents the amount of predictability between TNF Pharmaceuticals, time series from 23rd of November 2024 to 8th of December 2024 and 8th of December 2024 to 23rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of TNF Pharmaceuticals, price movement. The serial correlation of 0.73 indicates that around 73.0% of current TNF Pharmaceuticals, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.73 | |
| Spearman Rank Test | -0.44 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
TNF Pharmaceuticals, lagged returns against current returns
Autocorrelation, which is TNF Pharmaceuticals, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting TNF Pharmaceuticals,'s stock expected returns. We can calculate the autocorrelation of TNF Pharmaceuticals, returns to help us make a trade decision. For example, suppose you find that TNF Pharmaceuticals, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
TNF Pharmaceuticals, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If TNF Pharmaceuticals, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if TNF Pharmaceuticals, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in TNF Pharmaceuticals, stock over time.
Current vs Lagged Prices |
| Timeline |
TNF Pharmaceuticals, Lagged Returns
When evaluating TNF Pharmaceuticals,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of TNF Pharmaceuticals, stock have on its future price. TNF Pharmaceuticals, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, TNF Pharmaceuticals, autocorrelation shows the relationship between TNF Pharmaceuticals, stock current value and its past values and can show if there is a momentum factor associated with investing in TNF Pharmaceuticals,.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether TNF Pharmaceuticals, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TNF Pharmaceuticals,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tnf Pharmaceuticals, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tnf Pharmaceuticals, Stock:Check out TNF Pharmaceuticals, Correlation, TNF Pharmaceuticals, Volatility and TNF Pharmaceuticals, Alpha and Beta module to complement your research on TNF Pharmaceuticals,. For information on how to trade TNF Stock refer to our How to Trade TNF Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
TNF Pharmaceuticals, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.